1. Comparison of BRCA versus non-BRCA germline mutations and associated somatic mutation profiles in patients with unselected breast cancer
- Author
-
Li Cao, Liping Guo, Bo Chen, Ning Liao, Chongyang Ren, Xuerui Li, Kai Li, Cheukfai Li, Yulei Wang, Han Han-Zhang, Lingzhu Wen, Jiali Lin, Jing Liu, Minghan Jia, Yingzi Li, Analyn Lizaso, Guochun Zhang, Yuchen Zhang, Guangnan Wei, and Hsiaopei Mok
- Subjects
Adult ,Aging ,Mutation rate ,Population ,DNA Mutational Analysis ,BRCA ,Breast Neoplasms ,Biology ,Germline ,Breast cancer ,Germline mutation ,breast cancer ,MUTYH ,medicine ,Missense mutation ,Humans ,Genetic Predisposition to Disease ,education ,skin and connective tissue diseases ,CHEK2 ,Germ-Line Mutation ,BRCA2 Protein ,education.field_of_study ,non-BRCA ,BRCA1 Protein ,PTEN Phosphohydrolase ,Cell Biology ,Middle Aged ,medicine.disease ,Checkpoint Kinase 2 ,Cancer research ,germline mutations ,somatic mutations ,Female ,Fanconi Anemia Complementation Group N Protein ,Research Paper - Abstract
The data on the phenotypes associated with some rare germline mutations in Chinese breast cancer patients are limited. The difference in somatic mutation profiles in breast cancer patients with germline BRCA and non-BRCA mutations remains unexplored. We interrogated the germline and somatic mutational profile of 524 Chinese breast cancer patients with various stages unselected for predisposing factors using a panel consisting of 520 cancer-related genes including 62 cancer susceptibility genes. We divided the patients into three groups according to germline mutations: Germline-BRCA1/2, Germline-others (non-BRCA) and Others (non-carriers). A total of 58 patients (11.1%) carried 76 likely pathogenic or pathogenic (LP/P) germline variants in 15 cancer predisposition genes. Germline BRCA1/2 mutations were detected from 29 (5.53%) patients; with 11 (2.10%) BRCA1 carriers and 18 (3.44%) BRCA2 carriers. In addition, LP/P germline mutations were detected in other genes including MUTYH (n=4), PALB2 (n=4), ATM (n=3), BRIP1 (n=3), CDH1 (n=3), RAD51C (n=3), CHEK2 (n=2), FANCA (n=2), PMS2 (n=2), TP53 (n=2), FANCI (n=1), FANCL (n=1) and PTEN (n=1). At least one variant of uncertain significance (VUS) was identified in 490 (93.5%) patients. Young age (P=0.011), premenopausal status (P=0.013), and breast/ovarian cancer family history (P=0.001) were correlated with germline mutations. Germline-BRCA1/2 group was detected with more missense (P=0.02) and less copy-number amplification (P=0.04) than Germline-others group. Meanwhile, Germline-others group and Others group are very similar (P>0.05). The mutation rates of AKT1, CCND1, FGFR1, and PIK3CA were different among the three groups. By investigating all breast and ovarian cancer-related genes listed in the US genetic guidelines, we identified 15 cancer susceptibility genes frequently mutated in the germline of our population and must be included in cancer predisposition screening. Our study contributed a better understanding of the tumor characteristics of patients with LP/P germline mutations.
- Published
- 2019